You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

NIMBEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nimbex, and what generic alternatives are available?

Nimbex is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in NIMBEX is cisatracurium besylate. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nimbex

A generic version of NIMBEX was approved as cisatracurium besylate by SANDOZ INC on February 3rd, 2012.

  Try a Trial

Summary for NIMBEX
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 63
Clinical Trials: 13
Patent Applications: 696
Drug Prices: Drug price information for NIMBEX
What excipients (inactive ingredients) are in NIMBEX?NIMBEX excipients list
DailyMed Link:NIMBEX at DailyMed
Drug patent expirations by year for NIMBEX
Drug Prices for NIMBEX

See drug prices for NIMBEX

Recent Clinical Trials for NIMBEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mahidol UniversityPhase 4
Makassed General HospitalN/A
Assiut UniversityPhase 2/Phase 3

See all NIMBEX clinical trials

US Patents and Regulatory Information for NIMBEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie NIMBEX cisatracurium besylate INJECTABLE;INJECTION 020551-001 Dec 15, 1995 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie NIMBEX PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 020551-003 Dec 15, 1995 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie NIMBEX PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 020551-002 Dec 15, 1995 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NIMBEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie NIMBEX cisatracurium besylate INJECTABLE;INJECTION 020551-001 Dec 15, 1995 ⤷  Try a Trial ⤷  Try a Trial
Abbvie NIMBEX cisatracurium besylate INJECTABLE;INJECTION 020551-001 Dec 15, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for NIMBEX

See the table below for patents covering NIMBEX around the world.

Country Patent Number Title Estimated Expiration
Lithuania 274 ⤷  Try a Trial
Japan S6043342 ⤷  Try a Trial
Hungary T67613 ⤷  Try a Trial
South Korea 0174284 ⤷  Try a Trial
Hong Kong 80196 Neuromuscular blocking agents ⤷  Try a Trial
Switzerland 683427 Composé d'isoquinoléine comme agents de blocage neuromusculaire. ⤷  Try a Trial
Italy 8048000 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.